53.17
전일 마감가:
$51.13
열려 있는:
$51.3
하루 거래량:
503.66K
Relative Volume:
1.17
시가총액:
$1.84B
수익:
-
순이익/손실:
$-91.00M
주가수익비율:
-14.49
EPS:
-3.67
순현금흐름:
$-74.38M
1주 성능:
-1.38%
1개월 성능:
+11.40%
6개월 성능:
-14.86%
1년 성능:
+27.75%
Disc Medicine Inc Stock (IRON) Company Profile
명칭
Disc Medicine Inc
전화
(617) 674-9274
주소
321 ARSENAL STREET, SUITE 101, WATERTOWN
IRON을(를) 다른 주식과 비교
주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
---|---|---|---|---|---|---|
![]()
IRON
Disc Medicine Inc
|
53.17 | 1.84B | 0 | -91.00M | -74.38M | -3.67 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
457.03 | 115.95B | 11.10B | -988.90M | -1.26B | -3.92 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
547.74 | 56.52B | 14.09B | 4.50B | 2.96B | 39.28 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
329.77 | 39.44B | 2.35B | -269.70M | -75.39M | -2.09 |
![]()
ARGX
Argen X Se Adr
|
545.11 | 35.14B | 2.58B | 1.06B | -1.28B | 16.33 |
![]()
ONC
Beone Medicines Ltd Adr
|
244.32 | 28.51B | 3.81B | -644.79M | -669.77M | -6.24 |
Disc Medicine Inc Stock (IRON) Upgrades & Downgrades
날짜 | 액션 | 분석자 | 등급 변경 |
---|---|---|---|
2025-06-11 | 재개 | Raymond James | Strong Buy |
2025-02-27 | 개시 | TD Cowen | Buy |
2024-11-05 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
2024-11-04 | 업그레이드 | Raymond James | Outperform → Strong Buy |
2024-10-23 | 개시 | Jefferies | Buy |
2024-10-16 | 개시 | Scotiabank | Sector Outperform |
2024-08-22 | 개시 | Wells Fargo | Overweight |
2024-04-01 | 다운그레이드 | Raymond James | Strong Buy → Outperform |
2023-12-19 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
2023-06-09 | 업그레이드 | Raymond James | Outperform → Strong Buy |
2023-06-07 | 개시 | H.C. Wainwright | Buy |
2023-05-17 | 개시 | Raymond James | Outperform |
2023-04-28 | 개시 | Cantor Fitzgerald | Overweight |
2023-04-21 | 개시 | Stifel | Buy |
2023-04-20 | 개시 | Morgan Stanley | Overweight |
2023-03-23 | 개시 | BMO Capital Markets | Outperform |
2023-02-28 | 개시 | SVB Securities | Outperform |
모두보기
Disc Medicine Inc 주식(IRON)의 최신 뉴스
Insider Sell: Jean Franchi Sells 2,000 Shares of Disc Medicine Inc (IRON) - GuruFocus
Disc Medicine (NASDAQ:IRON) Given Buy Rating at HC Wainwright - Defense World
Analysts Offer Predictions for Disc Medicine Q2 Earnings - Defense World
Raymond James Resumes Coverage on Disc Medicine (IRON) With a Strong Buy Rating - MSN
Disc Medicine stock price target maintained at $118 by H.C. Wainwright - Investing.com
Disc Medicine (IRON) Maintains Buy Rating and Price Target | IRO - GuruFocus
Disc Medicine (IRON) Maintains Buy Rating and Price Target | IRON Stock News - GuruFocus
Disc Medicine’s (IRON) Outperform Rating Reaffirmed at Wedbush - Defense World
First Week of December 19th Options Trading For Disc Medicine (IRON) - Nasdaq
Long Term Trading Analysis for (IRON) - news.stocktradersdaily.com
Disc Medicine shareholders vote on executive pay and board members By Investing.com - Investing.com Canada
Disc Medicine shareholders vote on executive pay and board members - Investing.com Australia
Disc Medicine Holds 2025 Annual Stockholders Meeting - TipRanks
Disc Medicine Presents Positive Clinical Data Updates Across Por - GuruFocus
Disc Medicine (IRON) Highlights Research Advances at EHA 2025 | - GuruFocus
Disc Medicine reports positive data from clinical programs at EHA By Investing.com - Investing.com South Africa
Disc Medicine reports positive data from clinical programs at EHA - Investing.com Australia
Disc Medicine Highlights Positive Clinical Data for Bitopertin, DISC-0974, and DISC-3405 at EHA 2025; Management to Host Corporate Update Call - Nasdaq
Disc Medicine Presents Positive Clinical Data Updates - GlobeNewswire
Disc Medicine Reports Breakthrough Clinical Data Across 3 Blood Disease Programs | IRON Stock News - Stock Titan
Disc Medicine (NASDAQ:IRON) Now Covered by Analysts at Raymond James - Defense World
10 Best Small-Cap Growth Stocks to Buy According to Analysts - Insider Monkey
IRON Stock: Disc Medicine (IRON) Receives Strong Buy Rating from - GuruFocus
California State Teachers Retirement System Sells 1,436 Shares of Disc Medicine, Inc. (NASDAQ:IRON) - Defense World
Cantor Fitzgerald Estimates Disc Medicine FY2026 Earnings - Defense World
Disc Medicine (IRON) Rated Strong Buy by Raymond James | IRON St - GuruFocus
Disc Medicine chief medical officer sells $149,800 in stock By Investing.com - Investing.com India
Insider Sell: William Savage Sells Shares of Disc Medicine Inc (IRON) - GuruFocus
Disc Medicine chief medical officer sells $149,800 in stock - Investing.com
Millennium Management LLC Buys Shares of 7,879 Disc Medicine, Inc. (NASDAQ:IRON) - Defense World
Ameriprise Financial Inc. Invests $335,000 in Disc Medicine, Inc. (NASDAQ:IRON) - Defense World
Bank of America Corp DE Reduces Position in Disc Medicine, Inc. (NASDAQ:IRON) - Defense World
Disc Medicine, Inc. (NASDAQ:IRON) Receives Average Rating of “Buy” from Analysts - Defense World
Disc Medicine, Inc. (NASDAQ:IRON) Shares Sold by Nuveen Asset Management LLC - Defense World
Disc Medicine to Participate in Upcoming Investor Conferences - GlobeNewswire
Disc Medicine Sets Double Conference Appearance: Jefferies and Goldman Sachs Healthcare Events - Stock Titan
BNP Paribas Financial Markets Invests $324,000 in Disc Medicine, Inc. (NASDAQ:IRON) - Defense World
Disc Medicine, Inc. (NASDAQ:IRON) Stock Position Raised by Deutsche Bank AG - Defense World
Medical Marijuana (OTCMKTS:MJNA) Stock Price Crosses Above 200 Day Moving Average – What’s Next? - Defense World
Disc Medicine Shows Improved Relative Price Performance; Still Shy Of Benchmark - MSN
Disc Medicine’s chief medical officer sells $334,128 in stock By Investing.com - Investing.com Canada
Disc Medicine’s chief medical officer sells $334,128 in stock - Investing.com
Porphyria Pipeline 2025: Groundbreaking Clinical - openPR.com
Disc Medicine, Inc. (NASDAQ:IRON) Shares Purchased by Northern Trust Corp - Defense World
Commit To Buy Disc Medicine At $35, Earn 14.1% Annualized Using Options - Nasdaq
Disc Medicine Announces Multiple Presentations Across Portfolio - GuruFocus
Disc Medicine, Inc. to Present Key Data from Hematology Portfolio at EHA 2025 Congress - Nasdaq
Disc Medicine Announces Multiple Presentations Across - GlobeNewswire
Disc Medicine Reveals First Disease-Modifying EPP Treatment Data Among 6 Clinical Updates at EHA 2025 - Stock Titan
Disc Medicine Inc (IRON) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Disc Medicine Inc 주식 (IRON) 내부자 거래
내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
---|---|---|---|---|---|---|---|
Franchi Jean M. | Chief Financial Officer |
Jun 16 '25 |
Sale |
52.26 |
2,000 |
104,519 |
67,530 |
자본화:
|
볼륨(24시간):